Cleared Traditional

K182454 - O2 Concepts Oxlife Independence Model 3...

K182454 is the FDA 510(k) clearance for O2 Concepts Oxlife Independence Model 3... by O2 Concepts, LLC. It is a Class 2 Anesthesiology device (product code CAW) cleared through the Traditional 510(k) pathway after a 104-day FDA review.

K182454 · O2 Concepts, LLC · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
104d
Days
Class 2
Risk

K182454 is an FDA 510(k) clearance for the O2 Concepts Oxlife Independence Model 301-0001. Classified as Generator, Oxygen, Portable within the CAW classification (a category for home-use oxygen therapy and respiratory devices), Class II - Special Controls.

Submitted by O2 Concepts, LLC (Middlebury, US). The FDA issued a Cleared decision on December 20, 2018 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5440 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all O2 Concepts, LLC devices

Submission Details

510(k) Number K182454 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 07, 2018
Decision Date December 20, 2018
Days to Decision 104 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 140d · This submission: 104d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code CAW Generator, Oxygen, Portable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - CAW Generator, Oxygen, Portable

All 75
Devices cleared under the same product code (CAW) and FDA review panel - the closest regulatory comparables to K182454.
Kingon P2 Oxygen Concentrator
K190304 · Qingdao Kingon Medical Science and Technology Co. · Feb 2020
Concentrator with Single battery pack, carry bag with shoulder strap, back pack shoulder straps, A, POC1 USB Bluetooth Dongle, POC1 Invacare Mobile Medical Application Accessory for use on iOS and Android Devices, Invacare Platinum Mobile Oxygen Concentrator with Connectivity
K191159 · Invacare Corporation · Aug 2019
CONTEC Oxygen Concentrator
K180837 · Contec Medical System Co., Ltd. · Jan 2019
Oxygen Concentrator
K172234 · Sysmed (China) Co., Ltd. · Jun 2018
Drive DeVilbiss iGo 2 Portable Oxygen Concentrator
K172648 · Devilbiss Healthcare, LLC · Mar 2018
SIMPLYGO PORTABLE OXYGEN CONCENTRATOR
K111885 · Respironics, Inc. · Nov 2011